WEIFANG, China, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced that it will issue financial results for the three months ended September 30, 2008 after the close of the stock market on Thursday, November 13, 2008. Management will conduct a conference call on Friday, November 14, 2008 at 9:00 A.M. Eastern Standard Time to discuss these results. A question and answer session will follow management's presentation.
Mr. Qingtai Liu (Chief Executive Officer), Ms. Yiru Melody Shi (CFO), and Ms. Michelle Wang (Investor Relations Manager) will be the primary speakers on the call.
A live webcast of the conference call will be available on the Investor Relations page of Shengtai Pharmaceutical's web site at http://www.shengtaipharmaceutical.com . Please visit the Web site at least 15 minutes early to register for the webcast and download any necessary audio software.
To participate, please call the following numbers ten minutes before the call start time:
Phone Number: +1-877-407-8035 (North America)
Phone Number: +1-201-689-8035 (International)
A replay of the call will be available through Friday, November 21,
2008, at 11:59 P.M. Eastern Standard Time. For the replay, please call:
Phone Number: +1-877-660-6853 (North America)
Phone Number: +1-201-612-7415 (International)
Account Number: 286
Conference ID Number: 302820
About Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary,
Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese
operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a
leading manufacturer and supplier of pharmaceutical grade gluc
|SOURCE Shengtai Pharmaceutical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved